| Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile B Paiva, T Paino, JM Sayagues, M Garayoa, L San-Segundo, M Martín, ... Blood, The Journal of the American Society of Hematology 122 (22), 3591-3598, 2013 | 172 | 2013 |
| Systematic comparison and assessment of RNA-seq procedures for gene expression quantitative analysis LA Corchete, EA Rojas, D Alonso-López, J De Las Rivas, NC Gutiérrez, ... Scientific reports 10 (1), 19737, 2020 | 157 | 2020 |
| SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status L Lopez-Corral, ME Sarasquete, S Beà, R García-Sanz, MV Mateos, ... Leukemia 26 (12), 2521-2529, 2012 | 128 | 2012 |
| The cellular origin and malignant transformation of Waldenström macroglobulinemia B Paiva, LA Corchete, MB Vidriales, R García-Sanz, JJ Perez, ... Blood, The Journal of the American Society of Hematology 125 (15), 2370-2380, 2015 | 95 | 2015 |
| A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control B Paiva, MB Vidriales, L Rosiñol, J Martínez-López, MV Mateos, EM Ocio, ... Leukemia 27 (10), 2056-2061, 2013 | 93 | 2013 |
| Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance B Paiva, LA Corchete, MB Vidriales, N Puig, P Maiso, I Rodriguez, ... Blood, The Journal of the American Society of Hematology 127 (15), 1896-1906, 2016 | 91 | 2016 |
| In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone EM Ocio, D Fernández-Lázaro, L San-Segundo, L López-Corral, ... Leukemia 29 (3), 705-714, 2015 | 90 | 2015 |
| Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies L López-Corral, LA Corchete, ME Sarasquete, MV Mateos, R García-Sanz, ... haematologica 99 (8), 1365, 2014 | 87 | 2014 |
| Genomic characterization of liver metastases from colorectal cancer patients JM Sayagués, LA Corchete, ML Gutiérrez, ME Sarasquete, ... Oncotarget 7 (45), 72908, 2016 | 85 | 2016 |
| Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential T Paíno, B Paiva, JM Sayagués, I Mota, T Carvalheiro, LA Corchete, ... Leukemia 29 (5), 1186-1194, 2015 | 85 | 2015 |
| Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development MC Herrero-Sánchez, C Rodríguez-Serrano, J Almeida, L San Segundo, ... Journal of hematology & oncology 9, 1-14, 2016 | 83 | 2016 |
| Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for … J Cañueto, J Burguillo, D Moyano-Bueno, A Viñolas-Cuadros, ... Journal of the American Academy of Dermatology 80 (1), 106-113. e2, 2019 | 72 | 2019 |
| Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis B Paiva, MV Mateos, LI Sanchez-Abarca, N Puig, MB Vidriales, ... Blood, The Journal of the American Society of Hematology 127 (9), 1151-1162, 2016 | 72 | 2016 |
| Genomic analysis of high-risk smoldering multiple myeloma L López-Corral, MV Mateos, LA Corchete, ME Sarasquete, J de la Rubia, ... haematologica 97 (9), 1439, 2012 | 64 | 2012 |
| The novel pan-PIM kinase inhibitor, PIM447, displays dual antimyeloma and bone-protective effects, and potently synergizes with current standards of care T Paino, A Garcia-Gomez, L González-Méndez, L San-Segundo, ... Clinical Cancer Research 23 (1), 225-238, 2017 | 60 | 2017 |
| Effects of IL-8 up-regulation on cell survival and osteoclastogenesis in multiple myeloma AB Herrero, A García-Gómez, M Garayoa, LA Corchete, JM Hernández, ... The American journal of pathology 186 (8), 2171-2182, 2016 | 51 | 2016 |
| Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma EM Algarín, A Díaz-Tejedor, P Mogollón, S Hernández-García, ... Haematologica 105 (3), e116, 2020 | 50 | 2020 |
| Genome-wide DNA copy number analysis of acute lymphoblastic leukemia identifies new genetic markers associated with clinical outcome M Forero-Castro, C Robledo, R Benito, M Abaigar, A Africa Martin, M Arefi, ... PLoS One 11 (2), e0148972, 2016 | 50 | 2016 |
| Factors regulating microRNA expression and function in multiple myeloma I Misiewicz-Krzeminska, P Krzeminski, LA Corchete, D Quwaider, ... Non-coding RNA 5 (1), 9, 2019 | 46 | 2019 |
| Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis B Paiva, J Martinez-Lopez, LA Corchete, B Sanchez-Vega, I Rapado, ... Blood, The Journal of the American Society of Hematology 127 (24), 3035-3039, 2016 | 46 | 2016 |
Norma C GutierrezUniversidad de SalamancaVerified email at usal.es
